Clinical Trials for Boston Pharmaceuticals

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Boston Pharmaceuticals

Clinical Trials (2)

A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

PHASE2Recruiting

42 participants

Started: Apr 9, 2025 · Completed: Dec 31, 2027

1 condition2 sponsors35 locations

A Study of BOS-580 in Obese Subjects at Risk for, or With Biopsy-confirmed, Nonalcoholic Steatohepatitis (NASH) With an Extension

PHASE2Active, not recruiting

231 participants

Started: Sep 30, 2021 · Completed: Nov 30, 2025

1 condition2 sponsors48 locations